Komori
Techno Medica (6678) · InitiativeUpdate to the composition of outside directors

Strengthening governance through the appointment of external personnel and an external whistleblowing hotline

First written in FY2016. 2 of 7 entries say "Advanced", first in FY2017. Latest entry: FY2024.

7entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017 – FY2018SoftenedFY2019RestatedFY2021 – FY20242016: 120162017: 120172018: 120182019: 120192020: 020202021: 120212022: 120222023: 020232024: 12024
Same theme, other companies

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2024Update to the composition of outside directorsAnnual report

    「The Audit and Supervisory Committee consists of 3 outside directors who are Audit and Supervisory Committee members, all 3 of whom are independent officers.」

    While maintaining an Audit and Supervisory Committee structure with 3 independent outside directors, the committee consisted, as of the filing date, of Ozeki Jun (尾関純), Hirai Yutaka (平井豊) and Kurogouchi Akiko (黒河内明子). The members of the supervisory structure involving external personnel have been updated.
  2. FY2022RestatedAnnual report

    「The Audit and Supervisory Committee consists of 3 outside directors who are Audit and Supervisory Committee members, all 3 of whom are independent officers, including 1 full-time Audit and Supervisory Committee member.」

    The company continues to maintain an Audit and Supervisory Committee structure with 3 independent outside directors.
  3. FY2021RestatedAnnual report

    「The Audit and Supervisory Committee consists of 3 outside directors who are Audit and Supervisory Committee members, all 3 of whom are independent officers, including 1 full-time Audit and Supervisory Committee member.」

    The company continues to maintain an Audit and Supervisory Committee structure with 3 independent outside directors.
  4. FY2019SoftenedAnnual report

    「The Audit and Supervisory Committee consists of 3 outside directors who are Audit and Supervisory Committee members, all 3 of whom are independent officers, including 1 full-time Audit and Supervisory Committee member.」

    The company has maintained a structure in which all outside directors serving as Audit and Supervisory Committee members are independent officers, but the number of members declined from 4 in the prior fiscal year to 3.
  5. FY2018AdvancedAnnual report

    「The Audit and Supervisory Committee consists of 4 outside directors who are Audit and Supervisory Committee members, all 4 of whom are independent officers, including 1 full-time Audit and Supervisory Committee member.」

    The company has confirmed an external supervisory structure in which all 4 outside directors who are Audit and Supervisory Committee members are independent officers, with 1 serving full-time.
  6. FY2017AdvancedAnnual report

    「The Audit and Supervisory Committee consists of 4 members: 1 full-time Audit and Supervisory Committee member who is also a director and 3 outside directors who are Audit and Supervisory Committee members, all 3 of whom are independent officers.」

    A system consisting of 1 full-time Audit and Supervisory Committee member and 3 independent outside directors has been established, demonstrating progress in the supervisory structure involving external personnel.
  7. FY2016First statedAnnual report

    「The company plans to nominate at the annual general meeting of shareholders a director candidate with extensive practical experience in corporate accounting and finance who can maintain an appropriate degree of tension with the current management team and rigorously supervise the business execution divisions. In addition, it plans to nominate at a shareholders’ meeting an outside director who is an attorney with extensive knowledge of corporate law and other matters and who has had no prior business relationship with the company. The company has also established an external channel for reporting suspected improper processing within the company and has made it possible to take appropriate action.」

    The company has presented the appointment of individuals with accounting and finance experience, an attorney selected with independence in mind, and the establishment of an external whistleblowing channel as measures to prevent recurrence.
Moved together

"Expansion of Recurring Sales through Related Consumables and Maintenance Services" moved the same way as this thread, in the same document, in 2 of its 7 moves.

22★12
  1. ★This thread
  2. 1Expansion of Recurring Sales through Related Consumables and Maintenance Services2×
  3. 2Risk of Loss of Trust Due to Defects in Medical-Related Equipment2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Techno Medica yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Strengthening governance through the appointment of external personnel and an external whistleblowing hotline | Techno Medica Co.,Ltd. (6678) | Komori